Ajanta Pharma share news and announcements
NSE: AJANTPHARMBSE: 532331Pharmaceuticals & BiotechnologyMid Cap
Last close ₹3,283.90up ₹13.30 (0.41%)BSE ₹3,281.15
Share price at the NSE close on 23 Oct 2026. Previous close ₹3,270.60.
52-week range of traded prices to 23 Oct 2026
₹2,382.00Low, 28 Oct 2025₹3,796.00High, 18 Aug 2026
- Next results date: the board meets on 30 Oct 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹41,035 Cr236th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 30 Jul 2026
- 36.2
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 5 May 2026
- 9.1
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 1.83%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 30 Jul 2026
- 27.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 30 Jul 2026
- 27.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 5 May 2026
- 0.05
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 1,54,84762.5% delivered
Ajanta Pharma routine notices
163 filed, newest first. Page 3 of 4.
Mar 2022
17 Mar · Routine
Feb 2022
Dec 2021
14 Dec · Routine
13 Dec · Routine
Oct 2021
30 Oct · Routine
Sep 2021
6 Sep · Routine
Aug 2021
23 Aug · Routine
Jul 2021
30 Jul · Routine
Jun 2021
2 Jun · Routine
May 2021
Apr 2021
Mar 2021
12 Mar · Routine
Feb 2021
22 Feb · Routine
3 Feb · Routine
Jan 2021
25 Jan · Routine
19 Jan · Routine
8 Jan · Routine
Dec 2020
17 Dec · Routine
Nov 2020
27 Nov · Routine
4 Nov · Routine
4 Nov · Routine
Oct 2020
26 Oct · Routine
Sep 2020
Jul 2020
Jun 2020
Mar 2020
Dec 2019
Sep 2019
Jun 2019
Apr 2019
Jan 2019
Oct 2018
Jul 2018
Apr 2018